MYELODYSPLASTIC SYNDROME side effect
What is MYELODYSPLASTIC SYNDROME ?Drugs associated with MYELODYSPLASTIC SYNDROME
ABATACEPT ACTOS ALEMTUZUMAB ALKERAN ALTACE AMLODIPINE AMOXICILLIN ARANESP ARAVA AROMASIN AVANDIA AVONEX AZATHIOPRINE BELATACEPT BETASERON BRIPLATIN BYETTA CAMPATH CARBOPLATIN CARMUSTINE CASODEX CELEBREX CILOSTAZOL CISPLATIN CLOZAPINE COMTAN CONGESCOR COREG CYCLOPHOSPHAMIDE CYTARABINE DACOGEN DANTROLENE DEXAMETHASONE DULOXETINE ENBREL ENDOXAN EPIRUBICIN ETOPOSIDE EXJADE FLUDARA FLUOROURACIL FOLIC FORADIL FORTEO GEFITINIB GEMCITABINE GLEEVEC HUMATROPE HUMIRA HYDROXYCHLOROQUI IFOSFAMIDE IMATINIB INTERFERON KEPPRA LAMICTAL LAMIVUDINE LIPITOR METHOTREXATE MICARDIS MITOMYCIN NEUPOGEN OMEPRAZOLE PARAPLATIN PEMETREXED PLAVIX PREDNISONE PROCRIT PROGRAF RANIBIZUMAB REBIF REMICADE REVLIMID RIBAVIRIN RITUXAN RITUXIMAB ROSUVASTATIN SEROQUEL SPIRIVA TAXOL TEMODAL THALOMID THYMOGLOBULIN TOSITUMOMAB TRETINOIN VALPROIC ZEFIXMYELODYSPLASTIC SYNDROME : Lipitor Side Effects Report #5647601-0
Physician from JAPAN reported LIPITOR problem on Feb 25, 2008. Male patient, 73 years of age, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . LIPITOR dosage: DAILY DOSE:5MG. During the same period patient was treated with ASPIRIN, NU LOTAN, ALLOPURINOL, MEXITIL, JUVELA, COMELIAN, TERNELIN, CINAL. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5650985-0
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Female patient, 71 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5651005-4
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 25, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5651006-6
RITUXAN problem was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Male patient, 42 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Interferon Side Effects Report #5651221-1
Physician from UNITED STATES reported INTERFERON ALFA problem on Feb 11, 2008. Female patient, 45 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5651484-2
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Female patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/KG, 1/MONTH. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5651495-7
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 25, 2008. Female patient, 49 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5651499-4
RITUXAN problem was reported by a Physician from UNITED STATES on Feb 25, 2008. Female patient, 45 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
MYELODYSPLASTIC SYNDROME : Enbrel Side Effects Report #5652981-6
Physician from GERMANY reported ENBREL problem on Feb 25, 2008. Female patient, weighting 54.45 lb, was diagnosed with juvenile arthritis, polyarthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pancytopenia, . ENBREL dosage: unknown. During the same period patient was treated with IMUREK, METHOTREXATE, BELOC ZOK, ESIDRIX, NORDITROPIN, INDOMETHACIN. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Carmustine Side Effects Report #5660861-5
CARMUSTINE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2007. Male patient, 42 years of age, was diagnosed with astrocytoma and was treated with CARMUSTINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CARMUSTINE dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Comtan Side Effects Report #5662951-X
Physician from JAPAN reported COMTAN problem on Feb 28, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, white blood cell count decreased, . COMTAN dosage: 300 MG/DAY. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Comtan Side Effects Report #5663994-2
COMTAN problem was reported by a Physician from JAPAN on Feb 28, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, white blood cell count decreased, . COMTAN dosage: 300 MG/DAY. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Alemtuzumab Side Effects Report #5669134-8
Physician from UNITED STATES reported ALEMTUZUMAB problem on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ALEMTUZUMAB dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Alemtuzumab Side Effects Report #5670250-5
ALEMTUZUMAB problem was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ALEMTUZUMAB dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Revlimid Side Effects Report #5671703-6
Physician from UNITED STATES reported REVLIMID problem on Mar 10, 2008. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/30/2007.
MYELODYSPLASTIC SYNDROME : Comtan Side Effects Report #5688224-7
COMTAN problem was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with COMTAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . COMTAN dosage: 300 MG. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Remicade Side Effects Report #5688285-5
Physician from UNITED STATES reported REMICADE problem on Mar 20, 2008. Female patient was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . REMICADE dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Spiriva Side Effects Report #5689635-6
SPIRIVA problem was reported by a Physician from BRAZIL on Mar 28, 2008. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . SPIRIVA dosage: unknown. During the same period patient was treated with TALOFILINA, ANCORON, CEWIN, FORADIL, LASIX, EPREX. Patient was hospitalized. Patient died on 01/01/2008.
MYELODYSPLASTIC SYNDROME : Exjade Side Effects Report #5621803-1
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Feb 04, 2008. Male patient, 88 years of age, was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . EXJADE dosage: 1500MG QD. Patient died.
MYELODYSPLASTIC SYNDROME : Omeprazole Side Effects Report #5623066-X
OMEPRAZOLE problem was reported by a Health Professional from NEW ZEALAND on Feb 11, 2008. Female patient, 76 years of age, was diagnosed with oesophagitis, essential hypertension and was treated with OMEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . OMEPRAZOLE dosage: unknown. During the same period patient was treated with CANDESARTAN, CIPROFLOXACIN, ACYCLOVIR, FLUCONAZOLE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Lipitor Side Effects Report #5635265-1
Physician from JAPAN reported LIPITOR problem on Feb 14, 2008. Male patient, 73 years of age, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . LIPITOR dosage: unknown. During the same period patient was treated with ASPIRIN, NU LOTAN, ALLOPURINOL, MEXITIL, JUVELA, COMELIAN, TERNELIN, CINAL. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5635516-3
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient, 71 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Forteo Side Effects Report #5635581-3
Consumer or non-health professional from UNITED STATES reported FORTEO problem on Feb 11, 2008. Female patient was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . FORTEO dosage: unknown. During the same period patient was treated with PROZAC, PREVACID. Patient died on 01/30/2008.
MYELODYSPLASTIC SYNDROME : Interferon Side Effects Report #5637329-5
INTERFERON ALFA problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, 56 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
MYELODYSPLASTIC SYNDROME : Interferon Side Effects Report #5637332-5
Physician from UNITED STATES reported INTERFERON ALFA problem on Feb 11, 2008. Female patient, 45 years of age, was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with RITUXIMAB, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5637690-1
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/KG, 1/MONTH. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5637691-3
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 11, 2008. Female patient, 49 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5639590-X
RITUXAN problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient, 45 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5639591-1
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 11, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with INTERFERON ALFA, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BLEOMYCIN. Patient died.
MYELODYSPLASTIC SYNDROME : Rituxan Side Effects Report #5639603-5
RITUXAN problem was reported by a Physician from UNITED KINGDOM on Feb 11, 2008. Male patient, 42 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, INTRON A. Patient died.
MYELODYSPLASTIC SYNDROME : Valproic Side Effects Report #5589006-7
Consumer or non-health professional from FRANCE reported VALPROIC ACID problem on Jan 02, 2008. Female patient, 63 years of age, was diagnosed with convulsion and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . VALPROIC ACID dosage: unknown. During the same period patient was treated with NEURONTIN. Patient recovered.
MYELODYSPLASTIC SYNDROME : Betaseron Side Effects Report #5593066-7
BETASERON problem was reported by a Health Professional from SWEDEN on Jan 11, 2008. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . BETASERON dosage: unknown. During the same period patient was treated with SELOKEN ZOC, DETRUSITOL, ENALAPRIL MALEATE, SIMVASTATIN, FURADANTIN, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Revlimid Side Effects Report #5643981-0
Pharmacist from UNITED STATES reported REVLIMID problem on Dec 21, 2007. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . REVLIMID dosage: 5 MG,1 IN 1 D, ORAL. Patient died on 12/04/2007.
MYELODYSPLASTIC SYNDROME : Pemetrexed Side Effects Report #5535863-X
PEMETREXED problem was reported by a Physician from CANADA on Nov 23, 2007. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, myeloid leukaemia, . PEMETREXED dosage: 765 MG, UNK. During the same period patient was treated with CISPLATIN. Patient died on 10/22/2007.
MYELODYSPLASTIC SYNDROME : Fluorouracil Side Effects Report #5543341-7
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Nov 29, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . FLUOROURACIL dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOMYCIN, PROLEUKIN, EPIRUBICIN, METHOTREXATE, LEUCOVORIN CALCIUM. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rosuvastatin Side Effects Report #5564363-6
ROSUVASTATIN problem was reported by a Physician from ARGENTINA on Dec 11, 2007. Male patient, weighting 216.1 lb, was diagnosed with cardiovascular event prophylaxis, hypertension and was treated with ROSUVASTATIN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ROSUVASTATIN dosage: unknown. During the same period patient was treated with TERLOC DUO, HYGROTON, ASPIRIN. Patient recovered.
MYELODYSPLASTIC SYNDROME : Actos Side Effects Report #5580212-4
Consumer or non-health professional from UNITED KINGDOM reported ACTOS problem on Dec 19, 2007. Male patient, 78 years of age, was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ACTOS dosage: unknown. During the same period patient was treated with CANDESARTAN, ATORVASTATIN CALCIUM, BENDROFLUMETHIAZIDE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Taxol Side Effects Report #5505184-X
TAXOL problem was reported by a Health Professional from JAPAN on Oct 31, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Taxol Side Effects Report #5508624-5
Health Professional from JAPAN reported TAXOL problem on Nov 06, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE, TOREMIFENE, ANASTROZOLE, DI INCADRONATE, MEDROXYPROGESTERONE ACETATE, CAPECITABINE, CYCLOPHOSPHAMIDE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Aranesp Side Effects Report #5510201-7
ARANESP problem was reported by a Physician from ITALY on Oct 26, 2007. Female patient was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ARANESP dosage: unknown. During the same period patient was treated with CARNITENE, ZEMPLAR, LEDERFOLIN, LANSOX, RAMIPRIL, CARDURA, PARLODEL, FERROUS GLUCONATE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Cilostazol Side Effects Report #5512868-6
Consumer or non-health professional from JAPAN reported CILOSTAZOL problem on Oct 19, 2007. Female patient was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CILOSTAZOL dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient recovered.
MYELODYSPLASTIC SYNDROME : Aranesp Side Effects Report #5519455-4
ARANESP problem was reported by a Physician from NETHERLANDS on Nov 08, 2007. Female patient was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, therapeutic response decreased, . ARANESP dosage: unknown. Patient recovered.
MYELODYSPLASTIC SYNDROME : Prednisone Side Effects Report #5521467-1
Consumer or non-health professional from UNITED STATES reported PREDNISONE problem on Oct 03, 2007. Male patient, 50 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . PREDNISONE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CARBOPLATIN, ETOPOSIDE, VINCRISTINE, CYCLOPHOSPHAMIDE, IFOSFAMIDE, RITUXIMAB. Patient recovered.
MYELODYSPLASTIC SYNDROME : Gemcitabine Side Effects Report #5522347-8
GEMCITABINE problem was reported by a Physician from JAPAN on Nov 08, 2007. Male patient, weighting 102.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . GEMCITABINE dosage: 900 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Gemcitabine Side Effects Report #5522350-8
Physician from JAPAN reported GEMCITABINE problem on Nov 08, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . GEMCITABINE dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient recovered.
MYELODYSPLASTIC SYNDROME : Endoxan Side Effects Report #5523205-5
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver, breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ENDOXAN dosage: unknown. During the same period patient was treated with PACLITAXEL, DOCETAXEL, CAPECITABINE, TAMOXIFEN CITRATE, TOREMIFENE CITRATE, ANASTROZOLE, DI INCADRONATE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Taxol Side Effects Report #5526213-3
Health Professional from JAPAN reported TAXOL problem on Nov 22, 2007. Female patient, 58 years of age, was diagnosed with metastases to liver, breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with ENDOXAN, DOCETAXEL, CAPECITABINE, TAXOTERE, TAMOXIFEN CITRATE, TOREMIFENE, ANASTROZOLE. Patient recovered.
MYELODYSPLASTIC SYNDROME : Belatacept Side Effects Report #5526805-1
BELATACEPT problem was reported by a Consumer or non-health professional from ARGENTINA on Nov 20, 2007. Female patient, 37 years of age, was diagnosed with renal transplant and was treated with BELATACEPT. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . BELATACEPT dosage: unknown. During the same period patient was treated with CELLCEPT, PREDNISONE. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Rituximab Side Effects Report #5527060-9
Physician from UNITED KINGDOM reported RITUXIMAB problem on Nov 14, 2007. Female patient, weighting 132.1 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pyrexia, sepsis, . RITUXIMAB dosage: 800 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Celebrex Side Effects Report #5528157-X
CELEBREX problem was reported by a Physician from FRANCE on Nov 19, 2007. Male patient, weighting 174.2 lb, was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . CELEBREX dosage: unknown. During the same period patient was treated with AMLOR, COKENZEN, MISOPROSTOL. Patient was hospitalized. Patient recovered.
MYELODYSPLASTIC SYNDROME : Actos Side Effects Report #5531361-8
Consumer or non-health professional from JAPAN reported ACTOS problem on Nov 16, 2007. Male patient, 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, . ACTOS dosage: 15 MG (15 MG, 1 D) PER ORAL. During the same period patient was treated with PANALDINE, BAYMYCARD, ULGUT, ISOSORBIDE MONONITRATE, GLIMICRON, RIZE, SERMION. Patient recovered.